Detail akcie Orion online

Business Summary: Orion Oyj, previously Orion Corporation, is a Finland-based company active within the pharmaceutical industry. The Company is engaged in the research and development, manufacture and marketing of human and veterinary pharmaceuticals and active pharmaceutical ingredients. The core therapy areas of the Company's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory diseases.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Orion Oyj revenues increased 23% to EUR1.89B. Net income increased 52% to EUR500.3M. Revenues reflect Innovative Medicines segment increase of 55% to EUR812.7M, Branded Products segment increase of 9% to EUR314.6M, North America segment increase of 30% to EUR481.1M, Other Europe segment increase of 23% to EUR530.2M. Net income benefited from Impairment of Intangibles Excl.